Clinical Scorecard: Link Between Fasting Plasma Glucagon Levels and Osteopenia/Osteoporosis in Chinese Individuals with Type 2 Diabetes
At a Glance
Category
Detail
Condition
Key Mechanisms
Elevated fasting plasma glucagon levels are linked to impaired bone metabolism, leading to increased bone fragility.
Target Population
Care Setting
Key Highlights
Fasting glucagon levels positively associated with serum bone turnover markers, indicating potential for increased bone fragility.
Guideline-Based Recommendations
Diagnosis
Management
Monitor fasting plasma glucagon levels as a potential indicator of bone health and consider interventions such as dietary changes or medications to manage glucagon levels.
Monitoring & Follow-up
Risks
Patient & Prescribing Data
Consider glucagon levels in the context of bone health and metabolic status; explore medications that may help regulate glucagon.
Clinical Best Practices
Integrate glucagon level assessments into routine diabetes management and educate patients on lifestyle modifications to mitigate osteoporosis risk.
